Dr. Bahroo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Phc 7th Floor
Washington, DC 20007Phone+1 202-444-8525
Education & Training
- Georgetown University HospitalFellowship, Movement and Memory Disorders, 2007 - 2009
- MedStar Health/Georgetown University HospitalResidency, Neurology, 2004 - 2007
- St Luke's University HospitalInternship, Transitional Year, 2003 - 2004
- Rowan University School of Osteopathic MedicineClass of 2003
- University of Medicine and Dentistry of New Jersey - Graduate School of Biomedical SciencesMSc, Physiology, 1998 - 2000
- Rutgers University Behavioral Health CareB.A., Biology, Minor in Psychology, 1993 - 1998
Certifications & Licensure
- VA State License 2007 - 2026
- DC State License 2007 - 2024
- PA State License 2003 - 2004
- American Board of Psychiatry and Neurology Neurology
- National Board of Physicians and Surgeons Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Resident Scholarship American Academy of Neurology, 2007
- String of Pearls Georgetown University Medical School, 2005
Publications & Presentations
PubMed
- 11 citationsPerspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study.Atul T. Patel, Theodore Wein, Laxman B. Bahroo, Ophélie Wilczynski, Carl Rios
JMIR Public Health and Surveillance. 2020-12-07 - 2 citationsPractical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease.Abhishek Lenka, Gianluca Di Maria, Guillaume Lamotte, Laxman Bahroo, Joseph Jankovic
Expert Review of Neurotherapeutics. 2022-06-01 - 30 citationsBotulinum Toxin Injection Techniques for the Management of Adult SpasticityHeather W. Walker, Michael Y. Lee, Laxman B. Bahroo, Peter Hedera, David Charles
PM & R. 2015-04-01
Journal Articles
- Approach to the management of psychosis in Parkinson’s DiseaseLenka A, Gomathinayagam V, Bahroo L, Annals of Movement Disorders, 9/2019
- Hyperkinetic Movement DisordersFarzal Z, Lamotte G, Bahroo L, Practical Neurology, 9/2019
- Parkinson’s Disease Treatment UpdateFarzal Z, Lamotte G, Bahroo L., Practical Neurology, 9/2019
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- BoNT/A immunogenicity: a systematic review of the literature.Lacroix-Desmazes S, Colosimo C, Bahroo L, International Neurotoxin Association Conference, Lisbon, Portugal, 1/14/2015
- Analyzing the Patient Journey for Patients Living with Spastic Paresis.Bowers D, Khan P, Dashtipour K, Bahroo L, Lee M.Y. Balcaitiene J, Evidente V, Academy of Physical Medical & Rehabilitation Annual Assembly, Boston, MA, 1/1/2015
- Analysis of Abobotulinum toxin A Seroconversion in Cervical Dystonia and Spasticity.Landen A, Bahroo L, International Neurotoxin Association Conference, Miami Beach, FL, 1/5/2012
- Join now to see all
Lectures
- The Spasticity and Movement Disorders IMPACT Initiative CME programWashington D.C - 1/11/2020
- Medication Induced Movement Disorders, Neurotoxin Education Institute (NEI) CongressColorado Springs, CO - 11/2019
- Neurotoxin Education SeriesWeb based - 6/2019
- Join now to see all
Professional Memberships
- Member
- Movement Disorders SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: